Safety, pharmacokinetics and pharmacodynamics of branebrutinib (BMS‐986195), a covalent, irreversible inhibitor of Bruton's tyrosine kinase: Randomised phase I, placebo‐controlled trial in healthy participants-Reference-Cited by-同舟云学术

Safety, pharmacokinetics and pharmacodynamics of branebrutinib (BMS‐986195), a covalent, irreversible inhibitor of Bruton's tyrosine kinase: Randomised phase I, placebo‐controlled trial in healthy participants

Published:2020-04-12 Issue:9 Volume:86 Page:1849-1859
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Catlett Ian M.¹^ORCID,Nowak Miroslawa¹,Kundu Sudeep¹,Zheng Naiyu¹^ORCID,Liu Ang¹,He Bing¹,Girgis Ihab G.¹,Grasela Dennis M.¹

Affiliation:

1. Bristol Myers Squibb Princeton NJ USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14290

Reference30 articles.

1. Tec family of protein-tyrosine kinases: an overview of their structure and function

2. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down‐regulated in T lymphocytes and plasma cells;Smith CI;J Immunol,1994

3. The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective

4. Specific Btk inhibition suppresses B cell– and myeloid cell–mediated arthritis

5. Enhanced Bruton's Tyrosine Kinase Activity in Peripheral Blood B Lymphocytes From Patients With Autoimmune Disease

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bruton’s tyrosine kinase: A promising target for treating systemic lupus erythematosus;International Immunopharmacology;2024-12

2. Targeting Bruton’s tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments;Advances in Rheumatology;2024-08-21

3. High-throughput kinetics in drug discovery;SLAS Discovery;2024-07

4. Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases;Autoimmunity Reviews;2024-05

5. A Comprehensive Review of Small-Molecule Inhibitors Targeting Bruton Tyrosine Kinase: Synthetic Approaches and Clinical Applications;Molecules;2023-12-11